ApoB and ApoA-I Kinetics in the ApoB-67 Mutation
Principal Investigator: Francine Welty
Abstract: [unreadable] DESCRIPTION (provided by applicant): Hypobetalipoproteinemia (HBLP) is characterized by low levels of apoB (<20-50 mg/dL), the main protein in low-density lipoprotein (LDL). The applicant has described HBLP due to a truncated apoB-67 in which affected family members have mean LDL-C levels of 39 mg/dL and HDL-C levels of 65 mg/dL (43% higher than normals) and lower rates of atherosclerosis compared to unaffected family members at 12-year follow-up. These findings suggest that this mutation may prevent the development of atherosclerosis; therefore, mechanisms for the low LDL-C and high HDL-C levels are clinically relevant. ApoB exists in two isoforms in plasma, apoB-100, produced as very low density lipoprotein (VLDL) apoB-100 in the liver and apoB-48, produced as chylomicrons in the intestine. Heterozygous apoB-67 subjects have one normal allele making apoB-100; therefore, apoB-100 levels would be predicted to be at least 50% of normal; however, they are only 24% of normal and apoB-48 levels are 11% of normal. With stable isotopes, the applicant has shown that the lower than expected levels of apoB-100 result from decreased secretion and increased catabolism of VLDL apoB-100 and decreased production of LDL apoB-100. The applicant now proposes to determine mechanisms for the low levels of apoB48 and high levels of HDL-C and apoA-I. Baseline kinetics in 19 normal subjects by the applicant showed that: 1) apoB48 pool size is determined by secretion rate and not fractional catabolic rate; 2) a lower secretion of apoB-48 from the intestine is associated with a lower secretion and increased catabolism of VLDL apoB-100; and 3) HDL apoA-I and apoB48 catabolism are inversely related. The specific aims of this grant are to: 1) perform kinetics for apoB and apoA-I in 16 apoB-67 subjects and compare to 19 controls already studied; 2) size HDL particles and determine their composition; and 3) perform intestinal biopsies to measure apoB mRNA level. The hypotheses to be tested are: 1) apoB-48 secretion will be 75% lower in apoB-67 subjects and account for low levels of apoB-48; 2) high levels of HDL-C and apoA-I will be due to decreased catabolism of apoA-I; 3) apoB-48 and HDL apoA-I catabolism will be inversely correlated; 4) HDL particles will be primarily composed of large, HDL2-sized alpha and pre-alpha1-3 Lp A-I only containing particles and be cholesterol-ester enriched; and 5) intestinal apoB mRNA levels will be 75% lower in apoB-67 subjects compared to controls. The apoB-67 mutation may provide insights into mechanisms of low LDL-C and high HDL-C levels and new and better therapies to lower cholesterol.
Funding Period: 1997-08-15 - 2009-06-30
more information: NIH RePORT
- Role of the estrogen and progestin in hormonal replacement therapy on apolipoprotein A-I kinetics in postmenopausal womenStefania Lamon-Fava
Lipid Metabolism Laboratory, Jean Mayer USDA Human Nutrition Research, Center on Aging, Tufts University, Boston, MA 02111, USA
Arterioscler Thromb Vasc Biol 26:385-91. 2006..Hormonal replacement therapy (HRT) affects plasma HDL cholesterol levels, with estrogen increasing HDL cholesterol levels and progestins blunting this effect. This study was designed to assess the mechanism responsible for these effects...
- The association between soy nut consumption and decreased menopausal symptomsFrancine K Welty
Division of Cardiology, Beth Deaconess Medical Center, Boston, Massachusetts 02215, USA
J Womens Health (Larchmt) 16:361-9. 2007..Epidemiological studies suggest a low incidence of hot flashes in populations that consume dietary soy. The present study examined the effect of soy nuts on hot flashes and menopausal symptoms...
- Effect of body mass index on apolipoprotein A-I kinetics in middle-aged men and postmenopausal womenFrancine K Welty
Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
Metabolism 56:910-4. 2007..Sixty-two percent of the variability in PR and 71% of the variability in FCR were due to BMI in men and only 3% and 23%, respectively, in women. In conclusion, BMI has a significant effect on apo A-I PR and FCR in men but not in women...
- Effect of soy nuts on adhesion molecules and markers of inflammation in hypertensive and normotensive postmenopausal womenMelita M Nasca
Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA, USA
Am J Cardiol 102:84-6. 2008....
- High-resolution magnetic resonance imaging enhanced with superparamagnetic nanoparticles measures macrophage burden in atherosclerosisKunio Morishige
Donald W Reynolds Cardiovascular Clinical Research Center at Harvard Medical School, Boston, MA, USA
Circulation 122:1707-15. 2010..Macrophage imaging may serve as a biomarker to identify subclinical inflamed lesions, to predict future risk, and to aid in the assessment of novel therapies...
- LC-MS-based method for the qualitative and quantitative analysis of complex lipid mixturesUlf Sommer
Mass Spectrometry Resource, Department of Biochemistry, Boston University School of Medicine, Boston, MA, USA
J Lipid Res 47:804-14. 2006..The methods described should be easily adaptable to most modern MS instrumentation...